Literature DB >> 21998286

Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.

Philip Rieder1, Beda Joos, Alexandra U Scherrer, Herbert Kuster, Dominique Braun, Christina Grube, Barbara Niederöst, Christine Leemann, Sara Gianella, Karin J Metzner, Jürg Böni, Rainer Weber, Huldrych F Günthard.   

Abstract

BACKGROUND: In the context of sexual transmission of human immunodeficiency virus type 1 (HIV-1), current findings suggest that the mucosal barrier is the major site of viral selection, transforming the complex inoculum to a small, homogeneous founder virus population. We analyzed HIV-1 transmission in relation to viral and host characteristics within the Zurich primary HIV-1 infection study.
METHODS: Clonal HIV-1 envelope sequences (on average 16 clones/patient) were isolated from the first available plasma samples during the early phase of infection from 145 patients with primary HIV-1 infection. Phylogenetic and tropism analyses were performed. Differences of viral diversities were investigated in association with several parameters potentially influencing HIV-1 transmission, eg, concomitant sexually transmitted infections (STIs) and mode of transmission.
RESULTS: Median viral diversity within env C2-V3-C3 region was 0.39% (range 0.04%-3.23%). Viral diversity did not correlate with viral load, but it was slightly correlated with the duration of infection. Neither transmission mode, gender, nor STI predicted transmission of more heterogeneous founder virus populations that were found in 16 of 145 patients (11%; diversity >1%). Only 2 patients (1.4%) were assuredly infected with CXCR4-tropic HIV-1 within a R5/X4-tropic--mixed population, as revealed and confirmed using several genotypic prediction algorithms and phenotypic assays.
CONCLUSIONS: Our findings suggest that transmission of multiple HIV-1 variants might be a complex process that is not dependent on mucosal factors alone. CXCR4-tropic viruses can be sexually transmitted in rare instances, but their clinical relevance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998286     DOI: 10.1093/cid/cir725

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  Phylogenetically resolving epidemiologic linkage.

Authors:  Ethan O Romero-Severson; Ingo Bulla; Thomas Leitner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

2.  Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits.

Authors:  Sheldon R Morris; Steven Paul Woods; Reena Deutsch; Susan J Little; Gabriel Wagner; Erin E Morgan; Robert K Heaton; Scott L Letendre; Igor Grant; Davey M Smith
Journal:  J Neurovirol       Date:  2013-10       Impact factor: 2.643

3.  Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Authors:  Muhammad Shoaib Arif; James Hunter; Ana Rachel Léda; Jean Paulo Lopes Zukurov; Sadia Samer; Michelle Camargo; Juliana Galinskas; Esper Georges Kallás; Shirley Vasconcelos Komninakis; Luiz Mario Janini; Maria Cecilia Sucupira; Ricardo Sobhie Diaz
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

Authors:  Lucy A McNamara; Janani A Ganesh; Kathleen L Collins
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells.

Authors:  Johannes Nemeth; Valentina Vongrad; Karin J Metzner; Victoria P Strouvelle; Rainer Weber; Patrick Pedrioli; Ruedi Aebersold; Huldrych F Günthard; Ben C Collins
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

6.  Determinants of HIV-1 broadly neutralizing antibody induction.

Authors:  Peter Rusert; Roger D Kouyos; Claus Kadelka; Hanna Ebner; Merle Schanz; Michael Huber; Dominique L Braun; Nathanael Hozé; Alexandra Scherrer; Carsten Magnus; Jacqueline Weber; Therese Uhr; Valentina Cippa; Christian W Thorball; Herbert Kuster; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Jacques Fellay; Roland R Regoes; Huldrych F Günthard; Alexandra Trkola
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

7.  Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.

Authors:  Sara Gianella; Sanjay R Mehta; Jason A Young; Milenka V Vargas; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2012-10-03       Impact factor: 3.616

8.  Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen.

Authors:  Sara Gianella; Sanjay R Mehta; Matthew C Strain; Jason A Young; Milenka V Vargas; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

9.  Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.

Authors:  Cormac Cosgrove; James E Ussher; Andri Rauch; Kathleen Gärtner; Ayako Kurioka; Michael H Hühn; Krista Adelmann; Yu-Hoi Kang; Joannah R Fergusson; Peter Simmonds; Philip Goulder; Ted H Hansen; Julie Fox; Huldrych F Günthard; Nina Khanna; Fiona Powrie; Alan Steel; Brian Gazzard; Rodney E Phillips; John Frater; Holm Uhlig; Paul Klenerman
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

10.  HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection.

Authors:  Yik Lim Kok; Valentina Vongrad; Sandra E Chaudron; Mohaned Shilaih; Christine Leemann; Kathrin Neumann; Katharina Kusejko; Francesca Di Giallonardo; Herbert Kuster; Dominique L Braun; Roger D Kouyos; Huldrych F Günthard; Karin J Metzner
Journal:  JCI Insight       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.